These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8603016)
1. Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Nierodzik ML; Bain RM; Liu LX; Shivji M; Takeshita K; Karpatkin S Br J Haematol; 1996 Feb; 92(2):452-7. PubMed ID: 8603016 [TBL] [Abstract][Full Text] [Related]
2. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Nierodzik ML; Klepfish A; Karpatkin S Thromb Haemost; 1995 Jul; 74(1):282-90. PubMed ID: 8578473 [TBL] [Abstract][Full Text] [Related]
3. The cleaved peptide of PAR1 is a more potent stimulant of platelet-endothelial cell adhesion than is thrombin. Claytor RB; Michelson AD; Li JM; Frelinger AL; Rohrer MJ; Garnette CS; Barnard MR; Krueger LA; Furman MI J Vasc Surg; 2003 Feb; 37(2):440-5. PubMed ID: 12563219 [TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Nierodzik ML; Chen K; Takeshita K; Li JJ; Huang YQ; Feng XS; D'Andrea MR; Andrade-Gordon P; Karpatkin S Blood; 1998 Nov; 92(10):3694-700. PubMed ID: 9808563 [TBL] [Abstract][Full Text] [Related]
5. Recombinant fragment of von Willebrand factor AR545C inhibits platelet binding to thrombin and platelet adhesion to thrombin-treated endothelial cells. Dardik R; Varon D; Eskaraev R; Tamarin I; Inbal A Br J Haematol; 2000 Jun; 109(3):512-8. PubMed ID: 10886196 [TBL] [Abstract][Full Text] [Related]
6. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Dardik R; Savion N; Kaufmann Y; Varon D Br J Cancer; 1998 Jun; 77(12):2069-75. PubMed ID: 9649116 [TBL] [Abstract][Full Text] [Related]
7. Thrombin receptor-activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. Shankar R; de la Motte CA; Poptic EJ; DiCorleto PE J Biol Chem; 1994 May; 269(19):13936-41. PubMed ID: 7514596 [TBL] [Abstract][Full Text] [Related]
8. Regulation of the thrombin receptor response in human endothelial cells. Storck J; Zimmermann ER Thromb Res; 1996 Jan; 81(1):121-31. PubMed ID: 8747527 [TBL] [Abstract][Full Text] [Related]
9. Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs. Chiu PJ; Tetzloff GG; Foster C; Chintala M; Sybertz EJ Eur J Pharmacol; 1997 Feb; 321(1):129-35. PubMed ID: 9083795 [TBL] [Abstract][Full Text] [Related]
10. Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure. Yang Z; Ruschitzka F; Rabelink TJ; Noll G; Julmy F; Joch H; Gafner V; Aleksic I; Althaus U; Lüscher TF Circulation; 1997 Apr; 95(7):1870-6. PubMed ID: 9107175 [TBL] [Abstract][Full Text] [Related]
11. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease. Kinlough-Rathbone RL; Perry DW; Packham MA Thromb Haemost; 1995 Jan; 73(1):122-5. PubMed ID: 7740483 [TBL] [Abstract][Full Text] [Related]
13. Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures. Pumiglia KM; Feinstein MB Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):253-60. PubMed ID: 7689831 [TBL] [Abstract][Full Text] [Related]
14. Functional expression of a human thrombin receptor in Sf9 insect cells: evidence for an active tethered ligand. Chen X; Earley K; Luo W; Lin SH; Schilling WP Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):603-11. PubMed ID: 8670076 [TBL] [Abstract][Full Text] [Related]
15. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446 [TBL] [Abstract][Full Text] [Related]
16. Agonist receptors and G proteins as mediators of platelet activation. Brass LF; Hoxie JA; Kieber-Emmons T; Manning DR; Poncz M; Woolkalis M Adv Exp Med Biol; 1993; 344():17-36. PubMed ID: 8209785 [TBL] [Abstract][Full Text] [Related]
17. The cleaved peptide of the thrombin receptor is a strong platelet agonist. Furman MI; Liu L; Benoit SE; Becker RC; Barnard MR; Michelson AD Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3082-7. PubMed ID: 9501219 [TBL] [Abstract][Full Text] [Related]
18. Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor. Ahn HS; Foster C; Boykow G; Arik L; Smith-Torhan A; Hesk D; Chatterjee M Mol Pharmacol; 1997 Feb; 51(2):350-6. PubMed ID: 9203642 [TBL] [Abstract][Full Text] [Related]
19. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators. Lau LF; Pumiglia K; Côté YP; Feinstein MB Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841 [TBL] [Abstract][Full Text] [Related]
20. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Nierodzik ML; Kajumo F; Karpatkin S Cancer Res; 1992 Jun; 52(12):3267-72. PubMed ID: 1596884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]